SJ Medical
SJ Medical
As a premier Bioresorbable Vascular Scaffolds Manufacturer and Exporter serving the Sydney metropolitan area and international markets, SJ Medical is at the forefront of the "Fourth Revolution" in interventional cardiology. Sydney, home to world-class institutions like the Westmead Health Precinct and the Victor Chang Cardiac Research Institute, has become a pivotal hub for the adoption of bio-adaptable medical devices.
GMP Factory Space
Cleanroom Standards
Global Export Countries
13485 Certified
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide. Our expansion into the Sydney market reflects our commitment to bringing high-tier MedTech to the Australian healthcare landscape.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team, many of whom have been engaged in the medical device industry for decades. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency.
Industrial Growth: Sydney’s "Innovation Corridor" stretching from Macquarie Park to the CBD is witnessing a surge in demand for bioresorbable materials. Unlike traditional metallic Drug-Eluting Stents (DES), our Bioresorbable Vascular Scaffolds (BVS) provide a temporary bridge that allows the artery to heal and regain its natural vasomotion. Local Sydney clinicians are increasingly favoring "Nothing Left Behind" strategies to reduce long-term complications like late stent thrombosis.
Sydney Applications: From the busy cath labs at St Vincent’s Hospital to regional clinics in New South Wales, the shift toward minimally invasive, bio-integrative solutions is clear. Our BVS products are designed to support the vessel during the critical 6-9 month healing period before undergoing natural hydrolysis into water and CO2. This is particularly beneficial for younger patients in Sydney who may require future interventions or bypass surgeries.
Regulatory Prowess: While we hold CE and ISO 13485 certifications, we understand the rigorous standards required by the Therapeutic Goods Administration (TGA) in Australia. SJ Medical’s commitment to quality ensures that every scaffold exported to Sydney meets or exceeds global benchmarks for radial strength and elution profiles.
Technological Synergy: We integrate AI-driven design with laser-cutting precision. Our Sirolimus-eluting scaffolds utilize a controlled release mechanism that perfectly matches the inflammatory cycle of the vascular wall, a feature highly praised by Australian cardiovascular researchers.
Our products are widely applied in minimally invasive procedures involving both coronary and peripheral vascular systems. They play an important role in the diagnosis and treatment of vascular diseases, helping to improve procedural efficiency while enhancing patient safety and recovery in Australian clinical settings.
SJ Medical strictly adheres to international quality standards. The company has obtained CE certification, ISO 13485 quality management system certification, and CFDA approval, along with free sale certificates, demonstrating our strong commitment to product quality.
With long-term partnerships in Italy, Spain, France, and the Netherlands, SJ Medical is now strengthening its footprint in Sydney, Australia. We ensure seamless logistics and technical support for all our Oceanic partners.
Our commitment to the Sydney cardiovascular market is backed by years of R&D and a deep understanding of bioresorbable polymers. By choosing our scaffolds, Sydney healthcare providers benefit from:
For more information on our Bioresorbable Vascular Scaffolds or to request a technical data sheet for your Sydney-based medical facility, please reach out to our export department today.
